Zobrazeno 1 - 10 of 13 pro vyhledávání: '"K M, Rowland"'
1
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer
Autor: J A, Bonner, J A, Sloan, K M, Rowland, G G, Klee, J W, Kugler, J A, Mailliard, M, Wiesenfeld, J E, Krook, A W, Maksymiuk, E G, Shaw, R S, Marks, E A, Perez
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(2)
The level of serum neuron-specific enolase (NSE) has been implicated as a prognostic factor for patients with small cell lung cancer (SCLC). A prospective evaluation was undertaken to assess the prognostic significance of pretreatment NSE and treatme
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e973dc83764f1a73a29ffdeb37ccd5ae
https://pubmed.ncbi.nlm.nih.gov/10690544
Zobrazit plný text záznamu
2
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy
Autor: J A, Martenson, T G, Shanahan, M J, O'Connell, C D, Cobau, G, Schroeder, P A, Burch, R, Levitt, K M, Rowland
Publikováno v: Cancer. 86(4)
This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin.Pelvic radiation therapy consisted of 50.4-54 gray (Gy) administered in 28-30 fractions. Syst
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a9988d05cc34505bed76712d0aba1d8
https://pubmed.ncbi.nlm.nih.gov/10440700
Zobrazit plný text záznamu
3
A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): An NCCTG and SWOG study
Autor: A. A. Adjei, S. J. Mandrekar, G. K. Dy, J. R. Molina, D. R. Gandara, K. L. Allen Ziegler, P. J. Stella, K. M. Rowland, S. R. Schild, R. G. Zinner
Publikováno v: Journal of Clinical Oncology. 26:8080-8080
8080 Background: This phase II study was performed to evaluate the clinical efficacy and toxicity of pem (500 mg/m2 iv) combined with bev (15mg/kg iv) given every 3 weeks in the 2nd-line therapy of...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::856649e2fdc832425bdff92b3d2010a1
https://doi.org/10.1200/jco.2008.26.15_suppl.8080
Zobrazit plný text záznamu
4
81 SUBCUTANEOUS INTERLEUKIN-4 FOR RELAPSED NON-HODGKIN'S LYMPHOMA: A PHASE II TRIAL IN THE NORTH CENTRAL CANCER TREATMENT GROUP, NCCTG 91-78-51
Autor: S. M. Geyer, G. S. Soori, R. C. Tenglin, J. B. Allred, W. D. Putnam, T. E. Witzig, M. Wiesenfeld, K. M. Rowland, Paul J. Kurtin, D. M. Kurtz, A. M. Bernath, L. K. Tschetter
Publikováno v: Journal of Investigative Medicine. 55:S362.1-S362
Purpose Interleukin-4 (IL-4) is a pleiotropic cytokine that has in vitro antiproliferative activity against non-Hodgkin9s lymphoma (NHL). This phase II study was conducted to learn the efficacy and toxicity of IL-4 on patients with relapsing or resis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d2b3987459c72694ee39018c1288c02
https://doi.org/10.1136/jim-55-02-81
Zobrazit plný text záznamu
7
STRESS AND LEADER BEHAVIOR
Autor: L. L. Larson, K. M. Rowland
Publikováno v: Academy of Management Proceedings. 1972:185-188
The situational approach in leadership research is based on the belief that to obtain effective performance, different styles of leadership are required in different situations. Following the situa...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1215f6e2fe2858df78db2515f59c29f9
https://doi.org/10.5465/ambpp.1972.4981449
Zobrazit plný text záznamu
8
Current 'corrected' calcium concept challenged
Autor: R W Pain, B M Duncan, K M Rowland, P J Phillips
Publikováno v: BMJ. 4:617-619
There is wide individual variation in the number of millimoles of calcium bound per gram of albumin in the serum. Individual regression coefficients for serum calcium concentration on serum albumin concentration have been determined in 62 people (25
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b03596d742b6e0a7cb8f4857343b8be
https://doi.org/10.1136/bmj.4.5997.617
Zobrazit plný text záznamu
9
Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma
Autor: K M, Rowland, P, Bonomi, S G, Taylor, S, Maffey, S, Reddy, M S, Lee
Publikováno v: NCI monographs : a publication of the National Cancer Institute. (6)
Thirty-one patients with previously treated small cell bronchogenic carcinoma were treated with split-course radiation therapy and concurrent cisplatin and etoposide. Twenty-four patients (78%) had clinical partial or complete responses. Median survi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3c86f7633c389c2f093a06b8925dbe50
https://pubmed.ncbi.nlm.nih.gov/2832766
Zobrazit plný text záznamu
10
Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study
Autor: K M, Rowland, S G, Taylor, A S, Spiers, R C, DeConti, M R, O'Donnell, J, Showel, P B, Stott, L M, Milner, J C, Marsh
Publikováno v: Cancer treatment reports. 70(4)
Thirty-four patients with advanced, recurrent head and neck cancer were treated with cisplatin (100 mg/m2 on Day 1) and continuous-infusion 5-FU (1.0 g/m2/24 hours on Days 1-5) every 3-4 weeks. All but one patient had failed prior radiation therapy o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b1a0456c8d3d1b26a64942232828398
https://pubmed.ncbi.nlm.nih.gov/3698038
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje